114 related articles for article (PubMed ID: 19775667)
21. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
Jolly S; Kestin LL; Goldstein NS; Vicini FA
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
[TBL] [Abstract][Full Text] [Related]
22. Lobular carcinoma in situ.
Afonso N; Bouwman D
Eur J Cancer Prev; 2008 Aug; 17(4):312-6. PubMed ID: 18562954
[TBL] [Abstract][Full Text] [Related]
23. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
Aulmann S; Penzel R; Schirmacher P; Sinn HP
Verh Dtsch Ges Pathol; 2007; 91():208-13. PubMed ID: 18314616
[TBL] [Abstract][Full Text] [Related]
24. [Pelvic metastases revealing infiltrating lobular carcinoma of the breast].
Julié C; Arkwright S; Borghetti M; Taurelle R; Vildé F
Ann Pathol; 1997 Mar; 17(1):73-4. PubMed ID: 9162166
[No Abstract] [Full Text] [Related]
25. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ.
Fisher ER; Land SR; Fisher B; Mamounas E; Gilarski L; Wolmark N
Cancer; 2004 Jan; 100(2):238-44. PubMed ID: 14716756
[TBL] [Abstract][Full Text] [Related]
26. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
27. [The labelling index as a prognostic marker in breast carcinoma].
Bisail M; Nieddu S; Sarobba MG; Sanna G; Milia V; Ghì MG; Farris A
Minerva Med; 1994 Apr; 85(4):141-4. PubMed ID: 8028740
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.
Vo TN; Meric-Bernstam F; Yi M; Buchholz TA; Ames FC; Kuerer HM; Bedrosian I; Hunt KK
Am J Surg; 2006 Oct; 192(4):552-5. PubMed ID: 16978974
[TBL] [Abstract][Full Text] [Related]
29. Does neoadjuvant/adjuvant chemotherapy change the natural history of classic invasive lobular carcinoma?
Katz A
J Clin Oncol; 2005 Sep; 23(27):6796; author reply 6796-7. PubMed ID: 16170189
[No Abstract] [Full Text] [Related]
30. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
Rakha EA; Abd El Rehim D; Pinder SE; Lewis SA; Ellis IO
Histopathology; 2005 Jun; 46(6):685-93. PubMed ID: 15910600
[TBL] [Abstract][Full Text] [Related]
31. [Carcinoma in situ. Prognostic factors].
Trojani M
Arch Anat Cytol Pathol; 1994; 42(5):234-50. PubMed ID: 7872815
[No Abstract] [Full Text] [Related]
32. Intraoperative touch preparation cytology for margin assessment in breast-conservation surgery: does it work for lobular carcinoma?
Valdes EK; Boolbol SK; Ali I; Feldman SM; Cohen JM
Ann Surg Oncol; 2007 Oct; 14(10):2940-5. PubMed ID: 17632761
[TBL] [Abstract][Full Text] [Related]
33. [Lobular carcinoma in situ of the breast].
Llanos Muñoz M; Alonso Muñoz MC; Ojeda González B
Med Clin (Barc); 1994 Oct; 103(14):553-6. PubMed ID: 7799670
[No Abstract] [Full Text] [Related]
34. Risk counseling and management in patients with lobular carcinoma in situ.
Garreau JR; Nelson J; Look R; Walts D; Mahin D; Homer L; Johnson N
Am J Surg; 2005 May; 189(5):610-4; discussion 614-5. PubMed ID: 15862506
[TBL] [Abstract][Full Text] [Related]
35. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
[TBL] [Abstract][Full Text] [Related]
36. [Multiple primary breast cancer].
Volchenko NN
Arkh Patol; 1999; 61(4):21-5. PubMed ID: 10520424
[TBL] [Abstract][Full Text] [Related]
37. Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer.
van den Broek N; van der Sangen MJ; van de Poll-Franse LV; van Beek MW; Nieuwenhuijzen GA; Voogd AC
Breast Cancer Res Treat; 2007 Sep; 105(1):63-8. PubMed ID: 17115109
[TBL] [Abstract][Full Text] [Related]
38. Invasive lobular carcinoma in a hypoplastic breast.
Bassarova AV; Sedloev T; Christova SL; Trifonov DY; Nesland JM
Ultrastruct Pathol; 2002; 26(6):411-4. PubMed ID: 12537766
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
40. Invasive lobular carcinoma of the breast: role of endothelial lymphatic marker D2-40.
Laser J; Cangiarella J; Singh B; Melamed J; Chiriboga L; Yee H; Darvishian F
Ann Clin Lab Sci; 2008; 38(2):99-104. PubMed ID: 18469353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
